Andrew S. Day

Research interests

Publications

• Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data

  BMJ · 2021 · https://doi.org/10.1136/bmj.m4743

• Measurement of Fecal Calprotectin Improves Monitoring and Detection of Recurrence of Crohn's Disease After Surgery

  Gastroenterology · 2015 · https://doi.org/10.1053/j.gastro.2015.01.026

• Disease Activity Assessment in IBD

  Inflammatory Bowel Diseases · 2015 · https://doi.org/10.1097/mib.0000000000000341

• Microbial Dysbiosis in Pediatric Patients with Crohn's Disease

  Journal of Clinical Microbiology · 2012 · https://doi.org/10.1128/jcm.01396-12

• The Role of S100A12 as a Systemic Marker of Inflammation

  International Journal of Inflammation · 2012 · https://doi.org/10.1155/2012/907078

• Use of Enteral Nutrition for the Control of Intestinal Inflammation in Pediatric Crohn Disease

  Journal of Pediatric Gastroenterology and Nutrition · 2011 · https://doi.org/10.1097/mpg.0b013e318235b397

• Vitamin D Deficiency in Children with Inflammatory Bowel Disease

  Digestive Diseases and Sciences · 2011 · https://doi.org/10.1007/s10620-010-1544-3

• Faecal calprotectin, lactoferrin, M2-pyruvate kinase and S100A12 in severe ulcerative colitis: a prospective multicentre comparison of predicting outcomes and monitoring response

  Gut · 2010 · https://doi.org/10.1136/gut.2010.211755

• Severe Pediatric Ulcerative Colitis: A Prospective Multicenter Study of Outcomes and Predictors of Response

  Gastroenterology · 2010 · https://doi.org/10.1053/j.gastro.2010.02.047

• Campylobacter concisus and other Campylobacter species in children with newly diagnosed Crohnʼs disease

  Inflammatory Bowel Diseases · 2009 · https://doi.org/10.1002/ibd.21157

• Defensins and inflammation: The role of defensins in inflammatory bowel disease

  Journal of Gastroenterology and Hepatology · 2009 · https://doi.org/10.1111/j.1440-1746.2008.05772.x

• Sustained modulation of intestinal bacteria by exclusive enteral nutrition used to treat children with Crohn’s disease

  Alimentary Pharmacology & Therapeutics · 2008 · https://doi.org/10.1111/j.1365-2036.2008.03796.x

• Detection and Isolation of Campylobacter Species Other than C. jejuni from Children with Crohn's Disease

  Journal of Clinical Microbiology · 2008 · https://doi.org/10.1128/jcm.01949-08

• Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children

  Inflammatory Bowel Diseases · 2007 · https://doi.org/10.1002/ibd.20336

• Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease

  Scandinavian Journal of Gastroenterology · 2007 · https://doi.org/10.1080/00365520701416709

• Systematic review: nutritional therapy in paediatric Crohn’s disease

  Alimentary Pharmacology & Therapeutics · 2007 · https://doi.org/10.1111/j.1365-2036.2007.03578.x

• Exclusive enteral feeding as primary therapy for Crohn’s disease in Australian children and adolescents: A feasible and effective approach

  Journal of Gastroenterology and Hepatology · 2006 · https://doi.org/10.1111/j.1440-1746.2006.04294.x

• Oral tacrolimus treatment of severe colitis in children

  The Journal of Pediatrics · 2000 · https://doi.org/10.1067/mpd.2000.109193

• Helicobacter pyloriInduces Gastric Epithelial Cell Apoptosis in Association with Increased Fas Receptor Expression

  Infection and Immunity · 1999 · https://doi.org/10.1128/iai.67.8.4237-4242.1999

Current projects

No projects listed.